INTRODUCTION
Revised concepts of vitamin D metabolism have recently emerged from studies by DeLuca and associates (1) (2) (3) (4) , who have identified a variety of its metabolites which appear in mammals. Of these, 25-hydroxycholecalciferol has been demonstrated to be formed in the liver (4) and may be the compound which normally mediates the major biological effects of the vitamin. Storage phenomena, presumably of great importance in mammalian vitamin D-calcium physiology, have needed re-examination in the framework of this new information.
Indirect evidence that tissue storage does occur in mammals includes the following: (a) it may require many months to deplete a laboratory animal to the point of producing the deficiency state (5) ; (b) while the hepatic conversion of a pulse dose of vitamin D3 to the active metabolite, 25-HCC, occurs within a very few hours, and the subsequent disappearance of the tracer vitamin D3 from the serum occurs within 2 days (4), the biological effects of a modest single dose may persist for months (6, 7) ; and (c), the half-life of biological activity in plasma of humans after cessation of large doses has been estimated to be about 4 months (8) .
Attempts to define a storage site of vitamin D in tissues of man and other mammals have previously been unsuccessful. Most of the early studies of tissue distribution after a single (usually very large) dose of the vitamin recovered only about 10% of that administered, and this was found to be distributed rather uniformly among a variety of tissues (8) (9) (10) (11) . Nevertheless, the liver has been considered by some to be the most likely site for storage in mammals (12) .
In the present study, young rats with well established vitamin D deficiency were replenished with 14C ringlabeled vitamin Ds. Tissue levels of radioactivity were measured during repletion and also during a subsequent period of vitamin D deprivation. Our data show that adipose tissue acquired the greatest quantity of radioactivity and had the slowest rate of release. Chromatographic analysis showed that most of this radioactivity was associated with unaltered vitamin D,, and biological activity was found in the samples of adipose tissue. These results support the concept that body fat serves as a major site for storage of vitamin D in the rat.
METHODS
Experimental design. 66 (17) used to separate neutral lipids (hexane-diethyl ether-water, 135: 45: 3) effectively separated vitamin D3 from the other lipids present, with the exception of cholesterol. Chloroform was used to develop TLC plates when the purity of a vitamin Ds preparation was being tested.
Unlabeled vitamin D3 (Mann Research Labs. Inc., New York), and a lipid standard (Hormel model mixture No. 1) were used as reference markers and located by charring or by UV light adsorption after spraying the plate with Rhodamine 6G (Allied Chemical Co.) in acetone. Radioactivity was localized and measured by scraping successive 1 cm segments of the test lanes into vials containing 15 ml dioxane counting solution (17%o water) (16) .
Silicic acid column chromatography. Extracts from up to 3 g of tissue were prepared as for TLC and chromatographed on columns of silicic acid (Bio-Sil-HA,-325 mesh; Bio-Rad Labs, Richmond, Calif.); elution was carried out with a solvent gradient of increasing polarity, as described by DeLuca, Zile, and Neville (18) . Ionol (1,5-di-tert-butyl-2-hydroxy-3-methyl-benzene) was used as an antioxidant (19) . For tissues containing large amounts of lipid, it was necessary to use a layer of silicic acid and Hyflo-Supercel (1 g each) atop the silicic acid column as suggested by DeLuca et al. (18) and to load such extracts onto the column at room temperature. All columns were run at 40C.
Other methods. To measure biological activity, extracts were prepared as described for TLC and fed to rachitic rats according to the standard USP line test (20) . The concentration of calcium in serum was determined by atomic absorption spectroscopy (21) . Periosteal osteoid width was determined on calcified sections of the midtibial diaphysis by means of a filar micrometer eye piece (22) .
Total body fat was estimated by triplicate weighing of the shaved eviscerated carcass in air and in water (23) . The weight of total body fat was then calculated by the following relationship, which is derived from specific gravity and chemically determined total body fat of rats of similar size, sex, and on a similar diet (24) During the period of vitamin D8 administration, the concentration of radioactivity in various tissues steadily increased, always being highest in kidney ( Table I ). The total body mass of adipose tissue contained the greatest quantity of radioactivity at all periods of sampling, corresponding to an almost constant 10-12% of the cumulative dose. However, in other tissues this fraction decreased from about 6% of the first dose to 2-3% by the time the animal had received 12 doses (Table I ).
The concentration of radioactivity at the end of the 12 days of treatment varied from tissue to tissue, being highest in kidney (> 28,000 dpm/g), intermediate in fat from several different sources, blood, ileum and liver (4000-8000 dpm/g), and lowest in skin, muscle, bone, brain, and duodenum (< 3000 dpm/g) ( Table I ). There was a marked difference in the rate of fall of radioactivity in the different tissues examined. This is evident from the results in group B in which tissue radioactivity was monitored at more frequent time periods (Fig. 2) . In most tissues (cf. blood, liver, and kidney), radioactivity disappeared at a rapid rate for the first 3 wk and, thereafter, more slowly. This slower component very approximately could be fitted to an exponential function with a half time of 21 days for blood and 45-50 days for liver and kidney. In contrast, the rate of disappearance of radioactivity from fat was slow at all times, approximating an exponential rate with a half time of about 81 days during most of the period of observation.
The derived values for total radioactivity per organ or tissue are expressed as per cent of total dose per tissue in Table I . Adipose tissue retained the largest amount of radioactivity at the end of the period of vitamin D3 administration, as well as during the entire subsequent 88 day period of Vitamin D deprivation. Thus, 8 wk (day 71) after vitamin Ds had been discontinued, the concentration of radioactivity in adipose tissue (995-1835 dpm/g) far exceeded that in any other of the tissues examined (43-359 dpm/g) (Table II) : the fraction of the total administered dose represented by this radioactivity was still 4.9%, equivalent to 2.9 Ag. Skin ac- Identification of radioactivity. Chromatographic methods to identify further the chemical form of the radioactive molecules were applied to extracts of subcutaneous fat, blood plasma, liver, and kidney. To determine if the label were associated with lipids such as triglyceride (which might occur if the A ring containing the 1"C had been split and the resulting 2-carbon-labeled fragment reutilized by the different tissues), thin-layer chromatography with silicic acid or neutral alumina as adsorbant and a developing system to separate different neutral lipids and sterols were used (17) . Vitamin Da was thereby always separated effectively from mono-, di-, and triglycerides, free fatty acids, and phospholipids, more polar lipid, nonlipid material, and, often, also cholesterol. We found that in adipose tissue (subcutaneous and epididymal) obtained on days 7 and 14, 60% of the radioactivity migrated to the same position as reference nonradioactive vitamin Ds; the other 40% remained at the origin. In blood, liver, and kidney samples obtained on the 14th day, 24%, 39%, and 22% of the radioactivity migrated to the vitamin D3 area. Radioactivity was never found associated with the triglycerides extracted from these tissues. However, only those adipose tissue samples with the highest concentrations of radioactivity could be analyzed by means of TLC because the large amount of triglycerides present overloaded the adsorbant.
Because TLC, as performed in this study, does not separate the various metabolites of vitamin D3, gradient elution column chromatography on silicic acid was performed on extracts of pooled subcutaneous fat and also pooled plasma obtained from groups of three animals sacrificed on days 12 and 55. A representative chromatogram showed separation of radioactivity into four peaks which closely resembled the patterns reported by DeLuca and coworkers (1, 18) for other tissues (Fig. 3) . Recovery by this method was about 90% of that applied. 
Storage of Vitamin D. in Body Fat
After mild alkaline hydrolysis (26) of peak I, 40% of its radioactivity cochromatographed with unlabeled vitamin D3 (Fig. 3B) . This indicated that at least 40% of peak I material was present as esters of vitamin Ds. The notch in peak I was found in all runs and may indicate esters with different fatty acid composition. Peak II was identified by means of its chromatographic location (1, 18) . Its composition is unknown. As shown in Fig. 3B and 3C, the material in peak III migrated to areas corresponding to unlabeled marker vitamin Ds on both the silicic acid columns and thin-layer chromatography. Furthermore, peak III was shown to be biologically active in the USP line test. Therefore, we conclude that the radioactivity of peak III represented unaltered vitamin Ds. Peak IV had the same mobility as peak IV found by DeLuca using the same chromatographic system, and presumably consisted of a mixture of 25-HCC and other metabolically active and inactive polar metabolites of vitamin D3 (18, 27) .
The relative proportion of radioactivity in fat and plasma associated with each peak, 1 and 44 days after vitamin Ds supplements had been withdrawn, is shown in Fig. 4 . In subcutaneous fat, approximately 50% of the radioactivity was associated with peak III (unaltered vitamin); this proportion did not change in these two samples bracketing a 34 day time span. However, there was a 40% decrease in the total amount of unaltered vitamin Da (from 3.5 1Ag/g fat). During the same period, the proportion of total radioactivity in peak IV declined in fat from 21% to 12%, representing a 50% decline in total polar metabolites (from 1.3 to 0.48 Mg/g). In contrast, there was an increase in the proportion of radioactivity in peak I, representing doubling of content of total vitamin Da esters (from 0.45 to 0.84 /Ag/g). Plasma radioactivity was located primarily in peak IV, the unaltered vitamin (peak III) being found present only during and immediately after the period of supplementation. We did not detect any plasma radioactivity in peak I, in agreement with previous reports (26) .
Subcutaneous and epididymal fat, liver, kidney, and skin in depleted animals before the period of treatment were all found by bioassay to be free of antirachitic activity, but all these tissues were shown to contain activity throughout the entire period of observation after treatment. Effect of dose on tissue concentration of radioactivity. The general pattern was remarkably consistent for all groups, considering that the difference between the dose of group A and group C animals was 250-fold (Fig. 2) . The concentration of radioactivity expressed as a fraction of administered total dose never differed by more than a factor of 5 and usually by no more than a factor of 2. The striking exception to this pattern was the kidney, where there was a higher initial fraction of the dose retained and a much slower rate of loss in group A than from either of the groups B or C.
DISCUSSION
Reversal of a state of severe vitamin D deficiency by administering only radioactive vitamin Ds in the absence of sunlight permits us to make the assumption that subsequent tissue radioactivity in our experimental animals reflected the location and movement of all bodily vitamin D.
Although all tissues examined contained some radioactivity, indicating the presence of vitamin Da or its derivatives, adipose tissue was found to have the characteristics of a depot for the storage and release of the vitamin. This conclusion is supported by (a) the appearance within 24 hr of a substantial concentration of radioactivity in all five adipose tissue sites examined, (b) the subsequent very slow decrease in their radioactivity, (c) the consequent marked increase in total radioactivity in the adipose tissue relative to all other body tissues, and (d) the finding that a constant proportion of radioactivity in adipose tissue was present as unaltered vitamin D8, a form which was virtually absent from plasma throughout most of this same period of depletion. Thus, within 6 wk after vitamin Ds administration, 80% of all of the radioactivity measured in the body was present in adipose tissue, and more than half of this was found to have the chromatographic characteristics of unaltered FIGURE Chromatographic analysis of the adipose tissue extracts disclosed that the peaks of radioactivity corresponded to those of multiple forms of vitamin Ds reported by DeLuca and coworkers for other tissues (3, 18) . Of these, unaltered vitamin D3 (peak III) was present in the largest quantity throughout the entire experiment. Polar metabolites of vitamin Da (peak IV) made up the next largest fraction of the total radioactivty in fat. The rates of decrease of these two fractions were similar, a finding consistent with their serving as sources of vitamin D during deprivation and consistent with the possibility that unaltered vitamin D in fat is the source from which the polar metabolites in fat and blood are replenished during deprivation. However, with respect to peak IV materials, the interpretation of this observation is uncertain since peak IV material includes metabolites which lack biological activity (1, 2) in addition to those which are biologically active, such as 25-HCC. Furthermore, we do not know whether these polar metabolites of adipose tissue arose from liver, tissues other than liver, or were produced within the fat cells themselves.
After ceasing supplementation, a progressive increase in the total quantity of vitamin D8 esters (peak I) in fat was observed, whereas the content of all other forms of vitamin D3 was decreasing. Thus, by 6 wk after treatment was stopped, 20% of all radioactivity in fat was in the form of esters. It is known that a small quantity of these is formed during intestinal absorption (28, 29) , and they have been detected in liver and kidney (26, 30 (31, 32) to a high pharmacological dose), and that release is very slow and approximately proportional to the concentration of vitamin D in adipose tissue over this same large dose range. Thus, adipose tissue serves as a depot of large capacity which accumulates vitamin D proportionate to its concentration in plasma and releases it at a much slower rate that is proportionate to its concentration in fat. These features of accumulation and release would protect against toxicity during short periods of vitamin overdosage, would tend to maintain a relatively stable concentration in blood under natural conditions where absorption and production of the vitamin could vary significantly, and would provide continued maintenance of vitamin D in plasma for hepatic conversion to 25-HCC during a relatively prolonged period of low intake. The fact that the biological activity of plasma of humans falls exponentially after a pharmacological dose of vitamin D (8, 33) at a rate similar to that which we have observed in rats (i.e. ti 3-4 months cf. ti -80 days in rats) lends support to the concept that these same features may characterize the storage and release of vitamin D in humans.
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